CADTH | Search

Current Filters

Showing 61 - 70 results of 3579

Mekinist for Metastatic Melanoma - Details (Mekinist) (Last Updated: Nov 6, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Mekinist
Manufacturer:
GlaxoSmithKline
Submission Type:
Initial

Jakavi for myelofibrosis (Jakavi) (Last Updated: Jan 30, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Jakavi
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Initial

Istodax for Peripheral T-Cell Lymphoma - Details (Istodax) (Last Updated: Jun 26, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Istodax
Manufacturer:
Celgene Inc.
Submission Type:
Initial

Inlyta for metastatic renal cell carcinoma (mRCC) - Details (Inlyta) (Last Updated: Mar 22, 2013)

Note: The pCODR Provincial Advisory Group, PAG, has submitted a Request for Advice for this drug & indication on April 18, 2017. Please see the RFA: Inlyta for Metastatic Renal Cell Carcinoma details...

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Inlyta
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial

Halaven for Metastatic Breast Cancer - Details (Halaven) (Last Updated: Aug 20, 2012)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Halaven
Manufacturer:
Eisai Ltd.
Submission Type:
Initial

Gazyva for Chronic Lymphocytic Leukemia - Details (Gazyva) (Last Updated: Jun 26, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Gazyva
Manufacturer:
Hoffmann-La Roche Limited
Submission Type:
Initial

Vismodegib (Erivedge) for Advanced BCC - Details (Erivedge) (Last Updated: Jan 27, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Erivedge
Manufacturer:
Hoffmann-La Roche Limited
Submission Type:
Initial

Erbitux for Metastatic Colorectal Cancer - Details (Erbitux) (Last Updated: Jan 27, 2014)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Erbitux
Manufacturer:
Bristol-Myers Squibb Canada
Submission Type:
Initial
Download results as CSV